Precigen to Announce First Quarter 2024 Financial Results on May 14th and Host a Conference Call on June 3rd following the Late-breaking Oral Presentation for PRGN-2012 at the 2024 ASCO Annual Meeting Life Science Investing
Compass Pathways Announces First Quarter 2024 Financial Results and Business Highlights Psychedelics Investing
Compass Pathways announces durable improvement in symptoms through 12 weeks in open-label phase 2 study of COMP360 psilocybin in post-traumatic stress disorder Psychedelics Investing
Aligos Therapeutics Reports Recent Business Progress and First Quarter 2024 Financial Results Life Science Investing
Nuvectis Pharma, Inc. Reports First Quarter 2024 Financial Results and Business Highlights Life Science Investing
Thermo Fisher Scientific to Present at BofA Securities 2024 Health Care Conference on May 14 Medical Device Investing
Knight to Present at the 2024 RBC Capital Markets Global Healthcare Conference in New York City Pharmaceutical Investing
Arvinas Reports First Quarter 2024 Financial Results and Provides Corporate Update Life Science Investing
Atea Pharmaceuticals to Host First Quarter 2024 Financial Results Conference Call on May 14, 2024 Life Science Investing
